BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 22238053)

  • 1. Quantitative expression analysis of the apoptosis-related genes BCL2, BAX and BCL2L12 in gastric adenocarcinoma cells following treatment with the anticancer drugs cisplatin, etoposide and taxol.
    Korbakis D; Scorilas A
    Tumour Biol; 2012 Jun; 33(3):865-75. PubMed ID: 22238053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of gastric cancer cells with 5-fluorouracil/leucovorin and irinotecan induces distinct alterations in the mRNA expression of the apoptosis-related genes, including the novel gene BCL2L12.
    Korbakis D; Scorilas A
    Tumour Biol; 2009; 30(2):100-7. PubMed ID: 19440006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of MCF-7 cells with taxol and etoposide induces distinct alterations in the expression of apoptosis-related genes BCL2, BCL2L12, BAX, CASPASE-9 and FAS.
    Thomadaki H; Talieri M; Scorilas A
    Biol Chem; 2006 Aug; 387(8):1081-6. PubMed ID: 16895478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular response of HL-60 cells to mitotic inhibitors vincristine and taxol visualized with apoptosis-related gene expressions, including the new member BCL2L12.
    Thomadaki H; Floros KV; Scorilas A
    Ann N Y Acad Sci; 2009 Aug; 1171():276-83. PubMed ID: 19723066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations in mRNA expression of apoptosis-related genes BCL2, BAX, FAS, caspase-3, and the novel member BCL2L12 after treatment of human leukemic cell line HL60 with the antineoplastic agent etoposide.
    Floros KV; Thomadaki H; Florou D; Talieri M; Scorilas A
    Ann N Y Acad Sci; 2006 Dec; 1090():89-97. PubMed ID: 17384250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular Effects of Treatment of Human Colorectal Cancer Cells with Natural and Classical Chemotherapeutic Drugs: Alterations in the Expression of Apoptosis-related BCL2 Family Members, Including BCL2L12.
    Kontos CK; Avgeris M; Vassilacopoulou D; Ardavanis A; Scorilas A
    Curr Pharm Biotechnol; 2018; 19(13):1064-1075. PubMed ID: 30417787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cisplatin-induced apoptosis in HL-60 human promyelocytic leukemia cells: differential expression of BCL2 and novel apoptosis-related gene BCL2L12.
    Floros KV; Thomadaki H; Lallas G; Katsaros N; Talieri M; Scorilas A
    Ann N Y Acad Sci; 2003 Dec; 1010():153-8. PubMed ID: 15033711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular profile of breast versus ovarian cancer cells in response to treatment with the anticancer drugs cisplatin, carboplatin, doxorubicin, etoposide and taxol.
    Thomadaki H; Scorilas A
    Biol Chem; 2008 Nov; 389(11):1427-34. PubMed ID: 18783338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantification and study of the L-DOPA decarboxylase expression in gastric adenocarcinoma cells treated with chemotherapeutic substances.
    Korbakis D; Fragoulis EG; Scorilas A
    Anticancer Drugs; 2013 Mar; 24(3):291-9. PubMed ID: 23328075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast cancer cells response to the antineoplastic agents cisplatin, carboplatin, and doxorubicin at the mRNA expression levels of distinct apoptosis-related genes, including the new member, BCL2L12.
    Thomadaki H; Scorilas A
    Ann N Y Acad Sci; 2007 Jan; 1095():35-44. PubMed ID: 17404015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative expression analysis and prognostic significance of the novel apoptosis-related gene BCL2L12 in colon cancer.
    Kontos CK; Papadopoulos IN; Scorilas A
    Biol Chem; 2008 Dec; 389(12):1467-75. PubMed ID: 18844453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells.
    Xia L; Zhang D; Du R; Pan Y; Zhao L; Sun S; Hong L; Liu J; Fan D
    Int J Cancer; 2008 Jul; 123(2):372-379. PubMed ID: 18449891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of doxorubicin, oxaliplatin, and methotrexate administration on the transcriptional activity of BCL-2 family gene members in stomach cancer cells.
    Florou D; Patsis C; Ardavanis A; Scorilas A
    Cancer Biol Ther; 2013 Jul; 14(7):587-96. PubMed ID: 23792648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular analysis and prognostic impact of the novel apoptotic gene BCL2L12 in gastric cancer.
    Florou D; Papadopoulos IN; Scorilas A
    Biochem Biophys Res Commun; 2010 Jan; 391(1):214-8. PubMed ID: 19903463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytotoxic activity of sunitinib and everolimus in Caki-1 renal cancer cells is accompanied by modulations in the expression of apoptosis-related microRNA clusters and BCL2 family genes.
    Papadopoulos EI; Yousef GM; Scorilas A
    Biomed Pharmacother; 2015 Mar; 70():33-40. PubMed ID: 25776476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-182-5p regulates BCL2L12 and BCL2 expression in acute myeloid leukemia as a potential therapeutic target.
    Zhang S; Zhang Q; Shi G; Yin J
    Biomed Pharmacother; 2018 Jan; 97():1189-1194. PubMed ID: 29136958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative analysis of expression level of BCL2 and BAX genes in Hep-2 and HL-60 cells after treatment with etoposide.
    Královcová D; Pejchalová M; Rudolf E; Cervinka M
    Acta Medica (Hradec Kralove); 2008; 51(3):191-5. PubMed ID: 19271688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The novel member of the BCL2 gene family, BCL2L12, is substantially elevated in chronic lymphocytic leukemia patients, supporting its value as a significant biomarker.
    Papageorgiou SG; Kontos CK; Pappa V; Thomadaki H; Kontsioti F; Dervenoulas J; Papageorgiou E; Economopoulos T; Scorilas A
    Oncologist; 2011; 16(9):1280-91. PubMed ID: 21737576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of the apoptosis related genes BCL2 and BCL2L12 in breast cancer.
    Thomadaki H; Talieri M; Scorilas A
    Cancer Lett; 2007 Mar; 247(1):48-55. PubMed ID: 16647810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BCL2L12 is a novel biomarker for the prediction of short-term relapse in nasopharyngeal carcinoma.
    Fendri A; Kontos CK; Khabir A; Mokdad-Gargouri R; Scorilas A
    Mol Med; 2011; 17(3-4):163-71. PubMed ID: 21152697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.